Impact of retrospective data verification to prepare the ICON6 trial for use in a marketing authorization application

BACKGROUND: The ICON6 trial (ISRCTN68510403) is a phase III academic-led, international, randomized, three-arm, double-blind, placebo-controlled trial of the addition of cediranib to chemotherapy in recurrent ovarian cancer. It investigated the use of placebo during chemotherapy and maintenance (arm...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Clin Trials
Главные авторы: Embleton-Thirsk, Andrew, Deane, Elizabeth, Townsend, Stephen, Farrelly, Laura, Popoola, Babasola, Parker, Judith, Rustin, Gordon, Sydes, Matthew, Parmar, Mahesh, Ledermann, Jonathan, Kaplan, Richard
Формат: Artigo
Язык:Inglês
Опубликовано: SAGE Publications 2019
Предметы:
Data Management and Trial Conduct
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6801797/
https://ncbi.nlm.nih.gov/pubmed/31347385
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1740774519862528
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы